Hudson Institute of Medical Research (Hudson Institute) is presenting a poster on the Photosoft technology at the prestigious ComBio2022 industry conference to be held in Melbourne from 27-30th September 2022. ComBio is the Australian Society for Biochemistry and Molecular Biology's (ASBMB's) national biennial conference, which runs in conjunction with other societies and features world renowned international speakers. The poster presentation by Hudson Institute compares Photosoft compound with two other chlorin-based photosensitisers including Talaporfin sodium, which is approved in Japan for the treatment of lung cancer.
FULL ARTICLE
